Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report
- 15 July 1987
- Vol. 60 (2) , 173-177
- https://doi.org/10.1002/1097-0142(19870715)60:2<173::aid-cncr2820600209>3.0.co;2-f
Abstract
The results of treatment of infants with medulloblastoma using surgery and chemotherapy, without the use of radiation therapy, are reported. Both survival and outcome, in terms of growth, neurologic deficit, and intelligence are compared with the same parameters in children treated conventionally. Although preliminary, our results suggest that chemotherapy combined with surgery is a valid option for the treatment of infants with this type of neoplasm.This publication has 16 references indexed in Scilit:
- Survival of children with brain tumorsNeurology, 1986
- Neuropsychologic function in children with brain tumors: III. Interval changes in the six months following treatmentMedical and Pediatric Oncology, 1985
- Follow-up of children with brain tumorsCancer, 1984
- Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762) (MOPP vs OPP) in children with recurrent brain tumorsMedical and Pediatric Oncology, 1984
- Pediatric Brain TumorsPediatric Annals, 1983
- Intracranial tumors: response and resistance to therapeutic endeavors, 1970–1980International Journal of Radiation Oncology*Biology*Physics, 1982
- Quality of long-term survival following irradiation for intracranial tumors in children under the age of twoInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristineJournal of Neurosurgery, 1978
- Growth hormone deficiency in children with brain tumorsCancer, 1976
- The Use of Tissue Cultures in the Study of Brain TumorsPublished by S. Karger AG ,1971